TB-500 60mg — Vial Spec, Reconstitution Math & COA

Overview of TB-500 60mg Mass Specifications in Preclinical Protocols

In laboratory settings, evaluating synthetic peptides often requires significant aggregate mass to maintain consistency across parallel test groups or long-term continuous bioassays. A total mass specification of 60mg of target peptide allows research teams to prepare uniform stock solutions, minimizing lot-to-lot variability across extended experimental timelines. TB-500 is a synthetic derivative representing the active domain of naturally occurring Thymosin Beta-4, synthesized via solid-phase peptide synthesis (SPPS) to yield a highly purified lyophilized powder.

While specialized custom synthesis projects may occasionally call for a singular high-capacity glass vial containing 60mg of active lyophilized material, standard laboratory supply chains often distribute larger project masses across multiple standardized units. At PX1 Research, single-vial offerings typically focus on standard analytical sizes, such as our high-purity TB-500 10mg vial, which offer optimized stability and easier reconstitutions without risking repeated freeze-thaw degradation. Researchers seeking an aggregate total of 60mg routinely order multi-vial configurations to maintain aliquot integrity while securing full access to our extensive catalog of all research peptides.

Whether managing a singular high-yield vial or a multi-vial kit totaling 60mg of active material, precise reconstitution mathematical protocols remain essential. Maintaining strict control over solvent volume, solute concentration, micro-gram volumetric displacement, and thermal stability ensures reproducible results across cell culture media, histological assays, and animal tissue models.

Molecular Profile & Preclinical Mechanisms of Action

TB-500 is classified primary as a regeneration peptide, replicating the primary functional domain of the naturally occurring 43-amino-acid peptide Thymosin Beta-4 (Tβ4). The primary biological activity of TB-500 centers on its capacity to sequester G-actin (monomeric actin), thereby regulating actin polymerization dynamics within the cellular cytoskeleton. Cytoskeletal remodeling is a fundamental prerequisite for cellular motility, structural repair, and tissue architecture maintenance.

Preclinical studies suggest that TB-500 is investigated for promoting cell migration, blood-vessel formation (angiogenesis), and flexibility during soft-tissue and muscle-fiber recovery. In vitro models evaluating endothelial cell migration indicate that exposure to Thymosin Beta-4 fragments upregulates matrix metalloproteinases and facilitates cell movement through extracellular matrix barriers. Furthermore, animal studies assessing damaged muscle fibers demonstrate accelerated cellular infiltration and capillary sprouting when exposed to controlled concentrations of this sequence.

By modulating local inflammatory cascades and stimulating the recruitment of progenitor cells to damaged sites, TB-500 serves as a critical target in biomechanical and regenerative medicine research. Researchers utilize high-mass formulations to establish dose-response curves in preclinical models examining cardiac, musculoskeletal, and dermal tissue regeneration.

Reconstitution Math for 60mg Mass (1mL, 2mL, and 3mL Diluent Volumes)

Accurate concentration calculations are vital when preparing stock solutions from a 60mg total mass of lyophilized powder. Depending on the assay protocol and micro-pipetting limitations, researchers must select appropriate volumes of sterile reconstitution diluent, such as Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline (0.9% NaCl). Below are the precise mathematical outputs for dissolving 60mg (60,000 micrograms) of pure peptide across standard diluent volumes:

1. Reconstitution with 1.0 mL Diluent: Total Mass: 60 mg (60,000 µg) Total Volume: 1.0 mL Final Concentration: 60.0 mg/mL (60.0 µg/µL) In this ultra-concentrated state, a standard 10 µL pipetted aliquot delivers exactly 600 µg of active research compound. This concentrated solution requires complete dissolution verification to ensure no micro-particulates remain in suspension.

2. Reconstitution with 2.0 mL Diluent: Total Mass: 60 mg (60,000 µg) Total Volume: 2.0 mL Final Concentration: 30.0 mg/mL (30.0 µg/µL) At 30 mg/mL, a 10 µL volumetric draw yields 300 µg of peptide. This concentration balances solvent saturation with ease of volumetric metering for standard micro-centrifuge working solutions.

3. Reconstitution with 3.0 mL Diluent: Total Mass: 60 mg (60,000 µg) Total Volume: 3.0 mL Final Concentration: 20.0 mg/mL (20.0 µg/µL) With 3.0 mL of added diluent, each 10 µL draw contains exactly 200 µg of active sequence. This lower viscosity state is often preferred when preparing working dilutions for cell culture wells or micro-fluidic assays where precision dispensing of smaller mass increments is necessary. Researchers can utilize our online reconstitution calculator to instantly compute custom volume and concentration ratios for any target assay.

Aliquot Planning and Stability Management for Large Stock Quantities

Reconstituting a single large batch of 60mg total peptide presents specific stability challenges. Once a lyophilized peptide is dissolved in aqueous media, its chemical stability decreases over time, making it susceptible to peptide bond hydrolysis, oxidation, and aggregation. Repeatedly unsealing a primary stock vial or subjecting a single solution to multiple freeze-thaw cycles significantly degrades compound purity and compromises experimental reproducibility.

To maximize shelf life and maintain consistent structural integrity, research protocols should incorporate immediate aliquoting upon complete dissolution. After adding the chosen diluent and ensuring total dissolution via gentle swirling (avoiding vigorous vortexing or foam formation), the master solution should be divided into single-use, sterile working volumes using low-binding micro-centrifuge tubes.

For example, a 60mg solution dissolved in 3.0 mL (20 mg/mL concentration) can be aliquoted into thirty separate 100 µL micro-tubes, each containing 2.0 mg of peptide. Working aliquots intended for use within 24 to 72 hours may be stored at 2°C to 8°C. Aliquots designated for long-term storage must be flash-frozen and maintained at -20°C or -80°C. Once thawed for assay preparation, any remaining liquid should not be re-frozen.

Analytical Verification: Lot-Matched COA, HPLC, and Endotoxin Standards

High-mass research projects demand absolute analytical verification. PX1 Research subjects every production lot to comprehensive analytical testing, providing full transparency through an authentic, downloadable Certificate of Analysis (COA). Because mass quantities are frequently deployed in sensitive cellular and in vivo models, confirming both identity and purity is non-negotiable.

Purity is evaluated via High-Performance Liquid Chromatography (HPLC), which separates the target 43-amino-acid peptide sequence from potential synthesis byproducts, truncated fragments, or deletion sequences. PX1 Research enforces a strict target purity benchmark of ≥98.0% for all catalog compounds. Complementing HPLC, Mass Spectrometry (MS) is conducted to verify precise molecular weight, confirming structural identity against theoretical mass profiles.

For biological assays, endotoxin contamination presents a major confounding variable, capable of inducing non-specific inflammatory signaling in cell cultures or animal models. Every lot supplied by PX1 Research undergoes strict LAL (Limulus Amebocyte Lysate) endotoxin testing to guarantee endotoxin levels remain well below published research thresholds (<0.01 EU/µg). All synthesis and vial filling occur in GMP-compliant facilities operating under ISO 17025 accredited quality management systems.

Comparison: Single High-Mass Vials vs. Multi-Vial Configurations

When designing a research framework requiring 60mg total mass, principal investigators must decide between purchasing a single bulk vial or multiple smaller-capacity vials (e.g., six 10mg vials). While a single high-capacity vial reduces initial reconstitution steps, it introduces heightened risk: if contamination occurs during initial diluent injection, the entire 60mg inventory is compromised.

Conversely, distributing 60mg of total required inventory across six discrete 10mg vials (TB-500 10mg) offers substantial logistical advantages. Laboratory teams can reconstitute single 10mg vials as needed, maintaining the remaining 50mg in an ultra-stable lyophilized state at -20°C. This modular setup drastically reduces waste, prevents accidental mass contamination, and provides greater flexibility across staggered experimental schedules.

For large-scale university or institutional laboratories managing high-throughput screens, custom bulk production or multi-vial procurement plans can be established directly through our wholesale lab account portal. This ensures consistent lot-matching across all sub-units while securing volume allocation.

Comparative Analysis: TB-500, BPC-157, and GHK-Cu in Tissue Repair Models

In preclinical regenerative medicine research, TB-500 is frequently studied alongside or in comparison to other synthetically derived repair peptides. Understanding the distinct mechanisms of action across these compounds allows researchers to select the optimal model or design effective combination assays.

While TB-500 operates primarily through actin sequestration and vascular cell motility, BPC-157 acts through distinct signaling pathways, upregulating growth factors such as VEGFR2 and promoting tendon-to-bone healing and gastrointestinal mucosal repair. Meanwhile, GHK-Cu functions as a copper-binding tripeptide that modulates gene expression related to collagen synthesis, extracellular matrix remodeling, and skin tissue regeneration. Additionally, researchers examining systemic metabolic and repair pathways often compare these tissue-repair peptides with growth-hormone secretagogues such as CJC-1295 in comprehensive recovery models. Evaluating these distinct biochemical pathways allows research teams to map synergistic cellular responses in soft-tissue and vascular models.

Step-by-Step Laboratory Reconstitution Protocol

To ensure complete dissolution and preserve peptide stability during preparation, laboratory personnel should adhere to standardized aseptic techniques when handling 60mg total mass quantities:

1. Preparation & Sanitization: Allow the peptide vial and the bacteriostatic water diluent to reach room temperature. Sanitize the rubber stoppers of both vials with 70% isopropyl alcohol wipes and allow them to air-dry completely in a laminar flow hood. 2. Diluent Draw: Using a sterile, single-use syringe fitted with a precision needle, draw the exact pre-calculated volume of bacteriostatic water (e.g., 2.0 mL or 3.0 mL). 3. Reconstitution Injection: Angle the needle against the inner glass wall of the target vial containing the lyophilized powder. Slowly invert the syringe plunger, allowing the diluent to stream down the glass wall rather than spraying directly onto the delicate powder bed. 4. Dissolution: Allow the diluent to fully submerge the lyophilized cake. Gently roll and swirl the vial between your palms until the powder is fully dissolved. Do not shake or vortex vigorously. 5. Visual Inspection: Inspect the reconstituted liquid under direct light. The solution must appear completely clear, colorless, and free of visible particulates or cloudiness before proceeding to aliquotting or assay dosing.

Storage Conditions, Temperature Control, and Solvent Compatibility

Proper storage conditions are critical to preserving the biochemical activity of synthetic peptides. Lyophilized TB-500 is highly stable when stored away from light and moisture. In its un-reconstituted state, the powder should be maintained at -20°C for long-term storage (up to 24 months) or 2°C to 8°C for short-term project storage (up to 90 days).

Once reconstituted with bacteriostatic water containing 0.9% benzyl alcohol, the liquid solution remains chemically stable for up to 28 days when stored at 2°C to 8°C in a dedicated laboratory refrigerator. Avoid storing reconstituted solutions in frost-free freezers, as temperature fluctuations during automatic defrost cycles can degrade the peptide matrix.

When selecting solvents, Bacteriostatic Water is recommended for multi-use liquid storage due to its antimicrobial preservative properties. Sterile Normal Saline (0.9% NaCl) is suitable for immediate, single-day experimental applications where benzyl alcohol could interfere with live cell culture viability. Avoid using unbuffered sterile water for long-term liquid storage, as pH variations can accelerate peptide degradation.

Procurement for High-Throughput Research & Institutional Compliance

Acquiring high-purity peptides for academic, institutional, or private laboratory research requires absolute confidence in supplier quality and supply-chain transparency. PX1 Research manufactures all compounds within USA-based, state-of-the-art facilities, ensuring strict adherence to quality control benchmarks from raw material synthesis to final vial fill.

Research teams evaluating high-volume requirements can explore our extensive target catalog via our centralized research library hub or review our complete product portfolio under all research peptides. Every shipment includes full documentation, including lot-specific HPLC and MS analysis, ensuring your laboratory maintains compliance with internal quality assurance standards.

All products supplied by PX1 Research are strictly designated for laboratory research use only—in vitro and preclinical animal testing—and are explicitly not intended for human or veterinary medical use, clinical administration, or therapeutic application.